We performed VEGF-C KD in an additional cell line, MDA-MB-231, a basal B human breast cancer cell line that highly expresses VEGF-C receptors (Additional file 4: Figure S4) [14], and, similarly, we observed that the ALDH-positive population was significantly decreased (Figure 2D). Here, VEGFC is linked to breast carcinoma.